Peter Ellmark
Adjunct Professor at The Faculty of Engineering at Lund University | Kalmar County, Sweden
Peter Ellmark’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Research fellow at Immunteknologi in August 2026 - August 2026
Post doc at University of Sydney in August 2026 - August 2026
Adjunct Professor at The Faculty of Engineering at Lund University in February 2025 - Present
Chief Scientific Officer at Alligator Bioscience AB in January 2021 - Present
Vice President Discovery at Alligator Bioscience AB in January 2018 - January 2021
Principal Scientist at Alligator Bioscience AB in June 2013 - January 2021
Senior Research Scientist at Alligator Bioscience AB in September 2008 - May 2013
The Faculty of Engineering at Lund University, Assoc. Prof., August 2026
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s portfolio includes several promising drug candidates, with the CD40 agonist mitazalimab as its key asset. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X-Prime™, and novel drug candidates based on the RUBY™ bispecific platform with Orion Corporation. Out-licensed programs include AC101/HLX22, in Phase 2 development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. Alligator´s technology platform comprises the proprietary technologies ALLIGATOR-GOLD® and FIND®. ALLIGATOR-GOLD® is a human antibody library containing more than 60 billion unique antibody fragments. FIND® (Fragment Induced Diversity) is a molecular evolution technology for optimization of antibodies and other proteins. Immunotherapy of cancer: The immune system protects the body from attacks by pathogenic microorganisms (e.g. viruses and bacteria) and by cancer cells. Cancer cells usually evade the immune system, for example by producing immunosuppressive substances. Thus, although tumors often contain a large number of immune cells that should be able to attack the cancer cells, they are unable to do so due to the immunosuppression caused by the tumor. With immunotherapy, the ability of the immune system to fight cancer cells is improved in an effective manner, and the defense mechanisms used by the tumor are blocked or weakened. In addition, immune cells capable of destroying the cancer cells will survive in the body and thus protect it from metastases that may arise after treatment has ended. This "vaccination effect" is unique for immunotherapy.
Discover more about The Faculty of Engineering at Lund University
Chief Executive Officer hos Alligator Bioscience AB
Chief Executive Officer at Alligator Bioscience AB
(Jun 2021 – Present)
Aiming to make a difference to future medicine for patients by supporting biotech and innovative science.
UK based business consultancy and mentoring services to biotech globally.
Medical Scientist & Clinical Development Leader | Oncology & Immuno-Oncology | Translational Science & Clinical Strategy
• Provide scientific and operational leadership for clinical development programs in oncology and immuno-oncology, including mitazalimab (pancreatic cancer) and ATOR-4066.
• Lead cross-functional teams through study design, trial start-up, and execution, achieving key mile...
CFO
Vd at Gileus Consulting AB
(Jun 2015 – Present)
Director, Clinical Operation, Immune Oncology, Alligator Bioscience AB
Director, Clinical Operations at Alligator Bioscience AB
(May 2021 – Present)
VP Clinical Operations
VP Clinical Operations at Alligator Bioscience AB
(Jul 2023 – Present)
What is Peter Ellmark email address?
Email Peter Ellmark at [email protected]. This email is the most updated Peter Ellmark's email found in 2026.
How to contact Peter Ellmark?
To contact Peter Ellmark send an email to [email protected]. (updated on March 11, 2026)
What company does Peter Ellmark work for?
Peter Ellmark works for The Faculty of Engineering at Lund University.
What is Peter Ellmark's role at The Faculty of Engineering at Lund University?
Peter Ellmark is Adjunct Professor
What industry does Peter Ellmark work in?
Peter Ellmark works in the Biotechnology industry.
